Superdrol CAS:3381-88-2

Methyldrostanolone is a modified form of dihydrotestosterone. It differs by: 1) the addition of a methyl group at carbon 17-alpha, which helps protect the hormone during oral administration, and 2) the introduction of a methyl group at carbon-2 (alpha), which considerably increases the anabolic strength of the steroid by heightening its resistance to metabolism by the 3-hydroxysteroid dehydrogenase enzyme in skeletal muscle tissue.

Methyldrostanolone is an anabolic androgenic steroid comprised of the active steroidal hormone Methyldrostanolone. Superdrol is simply the Drostanolone hormone with an added methyl group at the 17th carbon position that allows the hormone to survive oral ingestion and officially classifies it as a C17-alpha alkylated (C17-aa) anabolic steroid. It also carries an added methyl group at the carbon two position, which greatly increases its anabolic power.

These slight alterations will also reduce Superdrol’s androgenicity compared to Masteron, which isn’t all that androgenic to begin with.

When looking at the traits of Methyldrostanolone, there is nothing all that remarkable about this steroid compared to many others.

The mere fact that it enjoyed years of grey legality is truly the only remarkable attribute. This isn’t to take away from the steroid’s ability, but is merely stated to clear up any confusion or misguided notions. Superdrol will notably enhance protein synthesis and nitrogen retention. Protein synthesis refers to the rate by which cells build proteins and nitrogen represents a key component in muscle tissue composition. The enhancement in both areas promotes a stronger anabolic atmosphere enabling the individual to build more lean tissue or preserve it during a calorie restricted state.